All Stories

Concentra curveball offer throws Acelyrin merger with Alumis into doubt

Acelyrin had been all set to merge into Alumis—but a surprise offer by Concentra Biosciences has thrown the deal into doubt.

Feb 21, 2025 - 13:42
 0
Concentra curveball offer throws Acelyrin merger with Alumis into doubt
Acelyrin had been all set to merge into Alumis—but a surprise offer by Concentra Biosciences has thrown the deal into doubt.
Read More

Tags:

Previous Article

D.R. Horton leads the way as Triad home builders show slight increase in closings

Next Article

How The Last Refuge, Heaven’s Door continue its climb in NuLu’s bourbon scene

Related Posts

AstraZeneca CEO defends 'fantastic' Alexion buyout in face of $753M hit from dropped drug

AstraZeneca CEO defends 'fantastic' Alexion buyout in f...

Feb 9, 2025  0

Repare unveils scale of layoffs with 75% of staff and chief medical officer heading for exit

Repare unveils scale of layoffs with 75% of staff and c...

Feb 25, 2025  0

Fierce Biotech Layoff Tracker 2025: Moderna lays off 50 employees; Spotlight winds down

Fierce Biotech Layoff Tracker 2025: Moderna lays off 50...

Feb 19, 2025  0